Scientists have made a breakthrough in developing new cancer treatments. They “superparadise” immune cells, which can still mass produce.
A new kind of “supersaliency” immune cells can be produced in mass quantities to fight cancer, as it became known during the latest immunotherapy, which features researchers at Imperial College London. According to them, this is a real breakthrough in the creation of a new generation of CAR-T therapies. Today this unique therapy involves reprogramming the most important immune cells for destruction of tumors. However, the cost is a staggering half a million dollars each patient because therapy is built individually.
However, the discovery by British scientists could significantly reduce this price tag and make CAR-T therapy is available for many. The researchers understood how to mass-produce immune cells for many patients. Theoretically, the cost of treatment can fall 10 times or even more. Scientists have created genetically reprogrammed version of natural T-cell killers called CAR19-iNKT.
In the course of experiments on laboratory mice’s immune cells destroy all the tumors in 60% of animals. Approximately 90% of the rodents lived long enough to talk about the effectiveness of treatment. Now in the next step, the scientists plan to test a new technique on humans. This is a further development of immunotherapy, which is considered the most promising direction in Oncology. (READ MORE)